Literature DB >> 10898672

beta-lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like beta-lactamase, OXA-30.

L K Siu1, J Y Lo, K Y Yuen, P Y Chau, M H Ng, P L Ho.   

Abstract

Ninety-one ampicillin-resistant Shigella flexneri strains from Hong Kong and Shanghai were studied for production of beta-lactamases. TEM-1-like and OXA-1-like enzymes were identified in 21 and 79% of the strains, respectively, by isoelectric focusing (IEF). No difference in the pattern of beta-lactamase production was found between strains from Hong Kong and Shanghai. Four ribotypes were detected. Over 88% of OXA-producing strains had the same ribotype. All TEM-1-like strains harbored a plasmid which hybridized positively with the bla(TEM) probe. Total DNA from OXA-1-like strains failed to hybridize or only hybridized weakly with an OXA probe. The OXA resistance was not transferable. OXA-1-like enzymes exhibited substrate and inhibition profiles similar to that of OXA-1 and were shown to have a pI of 7.3 by further IEF using a narrow-range ampholine gel. The gene encoding the OXA-1-like enzyme from one isolate (CH-07) was cloned, sequenced, and found to differ from bla(OXA-1) at codon 131 (AGA-->GGA; Arg to Gly), resulting in the novel designation OXA-30. The predominance of OXA-type enzymes in ampicillin-resistant S. flexneri suggests host preference for specific beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898672      PMCID: PMC90010          DOI: 10.1128/AAC.44.8.2034-2038.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Rarity of transferable beta-lactamase production by Klebsiella species.

Authors:  M Leung; K Shannon; G French
Journal:  J Antimicrob Chemother       Date:  1997-06       Impact factor: 5.790

2.  beta-lactamases in Shigella.

Authors:  H Schumacher; M Nir; B Mansa; A Grassy
Journal:  APMIS       Date:  1992-10       Impact factor: 3.205

3.  Transferable hyperproduction of TEM-1 beta-lactamase in Shigella flexneri due to a point mutation in the pribnow box.

Authors:  L K Siu; P L Ho; K Y Yuen; S S Wong; P Y Chau
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 4.  Inhibitor-resistant beta-lactamases.

Authors:  M H Nicolas-Chanoine
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

5.  Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy.

Authors:  M Matthew; A M Harris
Journal:  J Gen Microbiol       Date:  1976-05

6.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

7.  Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania.

Authors:  M M Navia; L Capitano; J Ruiz; M Vargas; H Urassa; D Schellemberg; J Gascon; J Vila
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 8.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

9.  Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995.

Authors:  Y W Chu; E T Houang; D J Lyon; J M Ling; T K Ng; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

10.  Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy.

Authors:  L G Burman; S Haeggman; M Kuistila; K Tullus; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

View more
  39 in total

1.  What's New in beta-lactamases?

Authors:  Patricia A. Bradford
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

2.  Inhibitor-resistant TEM-33 beta-lactamase in a Shigella sonnei isolate.

Authors:  D Sirot; C Chanal; R Bonnet; C De Champs; L Bret
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Cloning and expression of class A beta-lactamase gene blaA(BPS) in Burkholderia pseudomallei.

Authors:  Terence K M Cheung; P L Ho; Patrick C Y Woo; K Y Yuen; P Y Chau
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 4.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period.

Authors:  Elisenda Miró; Ferran Navarro; Beatriz Mirelis; Montserrat Sabaté; Alba Rivera; Pere Coll; Guillem Prats
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

6.  Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.

Authors:  D Aubert; L Poirel; J Chevalier; S Leotard; J M Pages; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

7.  Decreased susceptibility to cefepime in a clinical strain of Escherichia coli related to plasmid- and integron-encoded OXA-30 beta-lactamase.

Authors:  Véronique Dubois; Corinne Arpin; Claudine Quentin; Jeannette Texier-Maugein; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element.

Authors:  J Gangoue-Pieboji; V Miriagou; S Vourli; E Tzelepi; P Ngassam; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 9.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

10.  Whole-genome analysis of Salmonella enterica serovar Typhimurium T000240 reveals the acquisition of a genomic island involved in multidrug resistance via IS1 derivatives on the chromosome.

Authors:  Hidemasa Izumiya; Tsuyoshi Sekizuka; Hideo Nakaya; Masumi Taguchi; Akio Oguchi; Natsuko Ichikawa; Rika Nishiko; Shuji Yamazaki; Nobuyuki Fujita; Haruo Watanabe; Makoto Ohnishi; Makoto Kuroda
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.